Summary:
The primary objective of this study is to evaluate the efficacy of the Viveve treatment, SUI protocol, in improving mild to moderate stress urinary incontinence (SUI), assessed using the 1-hour Pad Weight Test for up to 12 months post-treatment.
Qualified Participants Must:
• Women 18 years and older with symptoms of stress urinary incontinence
• able and willing to comply with study requirements and instructions
Qualified Participants May Receive:
Health Checks, Assessments & Physical Examination in relation to study no cost to you. Access to study drug while in study and compensation for qualifying participants.